410.00GBp+0.61%Mkt Cap: 199.00M GBpP/E: 25.94Last update: 2026-05-13
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical De…
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)25.94
P/E (Forward)20.20
PEG—
P/B5.87
P/S3.99
EV/EBITDA16.55
EV/Revenue3.82
EPS (TTM)0.16
EPS (Forward)0.20
Cash Flow & Leverage
FCF Yield3.56%
FCF Margin14.30%
Operating CF10.32M GBp
CapEx (TTM)1.98M GBp
Net Debt/EBITDA-0.65
Net Debt-7.46M GBp
Technical
SMA 50385.42 (+6.4%)
SMA 200383.80 (+6.8%)
Beta0.34
S&P 52W Chg24.23%
Avg Vol (30d)105.94K
Avg Vol (10d)147.09K
Technical Indicators
RSI (14)65.3
MACD7.1631
MACD Signal3.8743
MACD Hist.+3.2888
BB Upper418.01 GBp
BB Middle389.85 GBp
BB Lower361.69 GBp
BB Width14.45%
ATR (14)17.17 GBp
Vol Ratio (20d)1.35x
52W Range
340.0067% of range445.00
52W High445.00 GBp
52W Low340.00 GBp
Profitability
Gross Margin80.62%
EBITDA Margin23.12%
Profit Margin14.29%
Oper. Margin19.71%
ROE20.13%
ROA14.65%
Revenue Growth13.60%
Earnings Growth42.40%
Balance Sheet
Debt/Equity0.18
Current Ratio4.13
Quick Ratio3.45
Book Value/Sh0.7030 GBp
Cash/Share0.2780 GBp
Dividends
Fwd Div Rate0.1400 GBp
Trail. Div Rate0.1420 GBp
Div. Yield3.44%
5Y Avg Yield2.51%
Payout Ratio87.44%
Ex-Div DateMar 19, 2026
Pay Date—
Ownership
Shares Out.47.95M
Float46.10M
Insiders2.40%
Institutions45.21%
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)471.43 GBp
Target Range400.00 GBp – 560.00 GBp
# Analysts7
Company
Market Cap199.00M GBp
Enterprise Value189.48M GBp
Revenue (TTM)49.54M GBp
Gross Profit37.46M GBp
Net Income (TTM)6.64M GBp
Revenue/Share1.038 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees270
Last Price410.00 GBp
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—